Mode
Text Size
Log in / Sign up

Meta-analysis finds no clinically significant outcome differences with postoperative glenoid retroversion ≥15° after aTSADoes shoulder implant angle matter for recovery? A new review suggests maybe not

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that postoperative glenoid retroversion ≥15° may not predict early clinical outcomes after aTSA, but long-term data are needed.

This systematic review and meta-analysis examined the association between postoperative glenoid component retroversion and clinical outcomes following primary anatomic total shoulder arthroplasty (aTSA). The analysis pooled data from 15 studies encompassing 1,190 shoulders, comparing outcomes between patients with postoperative glenoid retroversion <15° and those with retroversion ≥15°. The primary outcome was patient-reported clinical outcomes, with secondary outcomes including range of motion and complications.

The main finding was that no clinically significant differences were noted in patient-reported outcome scores, range of motion, or complications between the two retroversion groups. The analysis did not report specific effect sizes, absolute numbers, or statistical confidence intervals for these comparisons. The study setting and follow-up duration were not reported in the available data.

Safety and tolerability data, including adverse events and discontinuations, were not reported. A key limitation acknowledged by the authors is the need for future studies with long-term follow-up to assess the durability of these findings over time. The review's practice relevance is restrained, indicating it did not find evidence that postoperative glenoid component retroversion of <15° or ≥15° was associated with clinically significant differences in patient outcomes in the studied timeframe.

If you've had a total shoulder replacement, you might not realize your surgeon was likely aiming for a very specific angle when placing the new socket. Getting that angle just right is a major technical focus, based on the belief that it's crucial for a good result. A new analysis pooled data from 15 studies, looking at over 1,100 shoulder replacements. It compared patients whose final socket angle was less than 15 degrees with those whose angle was 15 degrees or more. The key finding? There were no clinically significant differences between the groups in how patients reported their pain and function, their range of motion, or their complication rates. This review suggests that, at least in the short to medium term, surgeons may not need to stress as much about hitting a perfect target angle. The data we have so far doesn't show it makes a noticeable difference to how people feel and move. However, the authors are clear that this is a look at the evidence we have now. A big caveat is that we don't yet know if a more angled implant might lead to problems like loosening or wear many years down the line. More studies with longer follow-up are needed to answer that.

What this means for you:
A specific shoulder implant angle may be less critical for short-term recovery than previously thought.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Surgeons commonly aim for less than 15 degrees of retroversion when positioning the glenoid component in anatomic total shoulder arthroplasty (aTSA). However, the effect of glenoid component retroversion on patient-reported clinical outcomes remains unclear. Here we present a systematic review and meta-analysis seeking evidence that the clinical results of aTSA are associated with postoperative glenoid component version. MATERIALS AND METHODS: Studies reporting postoperative clinical outcomes and measurements of glenoid component version after primary anatomic shoulder arthroplasties were identified and submitted for meta-analysis. Patients were divided into 2 groups based on postoperative glenoid component retroversion: (a) < 15° and (b) ≥ 15°. RESULTS: Fifteen articles (1,190 shoulders) met criteria for inclusion in our systematic review and meta-analysis. When comparing patient reported outcome scores, range of motion, and complications for shoulders with <15 or ≥15 degrees of glenoid component retroversion, no clinically significant differences were noted between the 2 groups. CONCLUSIONS: This review of the published literature did not find evidence that postoperative glenoid component retroversion of <15 or ≥15° was associated with clinically significant differences in patient outcomes. Future studies with long term follow-up will be necessary to demonstrate the effect of glenoid component retroversion on the clinical value, costs, and complications of aTSA.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.